The Negative Cross-Talk between SAG/RBX2/ROC2 and APC/C E3 Ligases in Regulation of Cell Cycle Progression and Drug Resistance
Related Experiment Video
Updated: Dec 9, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Shizhen Zhang1, Yanwen Shen1, Hua Li2
1Cancer Institute of the Second Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310029, China.
Abstract:
Anaphase-promoting complex/cyclosome (APC/C) is a well-characterized E3 ligase that couples with UBE2C and UBE2S E2s for substrate ubiquitylation by the K11 linkage. Our recent data show that SAG/RBX2/ROC2, a RING component of Cullin-RING E3 ligase, also complexes with these E2s for K11-linked substrate polyubiquitylation. Whether these two E3s cross-talk with each other was previously unknown. Here, we report that SAG competes with APC2 for UBE2C/UBE2S binding to act as a potential endogenous inhibitor of APC/C, thereby regulating the G2-to-M progression. As such, SAG knockdown triggers premature activation of APC/C, leading to mitotic slippage and resistance to anti-microtubule drugs. On the other hand, SAG itself is a substrate of APC/CCDH1 for targeted degradation at the G1 phase. The degradation-resistant mutant of SAG-R98A/L101A accelerates the G1-to-S progression. Our study reveals that the negative cross-talk between SAG and APC/C is likely a mechanism to ensure the fidelity of cell cycle progression.
Insights
The E3 ligase SAG inhibits the anaphase-promoting complex/cyclosome (APC/C) to regulate cell cycle progression. This cross-talk ensures accurate cell division and response to anti-microtubule drugs.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The anaphase-promoting complex/cyclosome (APC/C) is a crucial E3 ubiquitin ligase regulating cell cycle progression.
- APC/C utilizes UBE2C and UBE2S E2 enzymes for K11-linked substrate ubiquitylation.
- SAG (RBX2/ROC2), a component of Cullin-RING E3 ligases, also interacts with UBE2C/UBE2S for K11-linked polyubiquitylation.
Purpose of the Study:
- To investigate the potential cross-talk between the APC/C and SAG E3 ligases.
- To elucidate the role of SAG in regulating APC/C activity and cell cycle progression.
- To understand the feedback mechanism involving APC/C-mediated degradation of SAG.
Main Methods:
- Co-immunoprecipitation assays to study protein interactions.
- Western blotting to assess protein levels and ubiquitylation.
- Cell cycle analysis (e.g., flow cytometry) to monitor progression.
- RNA interference (RNAi) for gene knockdown.
- Site-directed mutagenesis to create degradation-resistant SAG variants.
Main Results:
- SAG competes with APC2 for binding to UBE2C/UBE2S, acting as an endogenous inhibitor of APC/C.
- SAG knockdown leads to premature APC/C activation, causing mitotic slippage and resistance to anti-microtubule agents.
- SAG is a substrate of APC/CCDH1, targeted for degradation during the G1 phase.
- A degradation-resistant SAG mutant (SAG-R98A/L101A) accelerates G1-to-S phase progression.
Conclusions:
- A negative cross-talk exists between SAG and APC/C, where SAG inhibits APC/C activity and is subsequently degraded by APC/C.
- This regulatory loop involving SAG and APC/C is critical for ensuring the fidelity of cell cycle progression.
- The interplay between SAG and APC/C impacts cellular responses to anti-microtubule drugs and cell cycle checkpoint control.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity
Positive Regulator Molecules
Positive Regulator Molecules
Anaphase Promoting Complex

